Sabra Health Care REIT, Inc. (FRA:SBC)
Germany · Delayed Price · Currency is EUR 15.24
-0.62 (-3.91%)
Last updated: Jan 28, 2026, 8:12 AM CET
Sabra Health Care REIT Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Rental Revenue | 377.28 | 381.5 | 376.27 | 400.59 | 396.72 | 430.58 |
Other Revenue | 327.49 | 284.18 | 233.26 | 96.31 | -25.8 | 158.59 |
| 747.06 | 702.64 | 644.62 | 531.95 | 388.24 | 600.82 | |
Revenue Growth (YoY | 9.34% | 9.00% | 21.18% | 37.02% | -35.38% | -10.08% |
Property Expenses | 250.03 | 227.09 | 195.25 | 162.61 | 141.2 | 131.55 |
Selling, General & Administrative | 50.83 | 50.07 | 47.47 | 39.57 | 34.67 | 32.76 |
Depreciation & Amortization | 177.9 | 169.62 | 183.09 | 187.78 | 178.99 | 176.74 |
Provision for Loan Losses | 0.77 | 0.57 | -0.19 | -0.14 | -3.94 | -1.86 |
Total Operating Expenses | 464.46 | 446.21 | 426 | 390.11 | 358.8 | 342.9 |
Operating Income | 282.6 | 256.43 | 218.62 | 141.84 | 29.44 | 257.92 |
Interest Expense | -111.13 | -114.77 | -112.96 | -105.47 | -98.63 | -100.52 |
Other Non-Operating Income | 0.04 | 0.04 | -1.9 | -1.1 | 0.37 | 2.25 |
EBT Excluding Unusual Items | 171.5 | 141.69 | 103.76 | 35.27 | -68.82 | 159.65 |
Gain (Loss) on Sale of Investments | - | - | - | -7.67 | -10.77 | -19.15 |
Gain (Loss) on Sale of Assets | 11.61 | 2.1 | -76.33 | -12.01 | 12.3 | 2.86 |
Total Insurance Settlements | 2.5 | 2.2 | 4.2 | - | - | - |
Asset Writedown | -6.67 | -18.47 | -14.33 | -94.04 | -9.5 | -4 |
Other Unusual Items | -2.15 | 0.2 | -1.54 | 2.09 | -34.62 | -0.23 |
Pretax Income | 176.78 | 127.72 | 15.76 | -76.36 | -111.41 | 139.13 |
Income Tax Expense | 1.73 | 1.01 | 2 | 1.24 | 1.85 | 0.71 |
Earnings From Continuing Operations | 175.06 | 126.71 | 13.76 | -77.61 | -113.26 | 138.42 |
Minority Interest in Earnings | 0.02 | - | - | - | - | - |
Net Income | 175.08 | 126.71 | 13.76 | -77.61 | -113.26 | 138.42 |
Net Income to Common | 175.08 | 126.71 | 13.76 | -77.61 | -113.26 | 138.42 |
Net Income Growth | 80.17% | 821.14% | - | - | - | 100.62% |
Basic Shares Outstanding | 238 | 233 | 231 | 231 | 219 | 206 |
Diluted Shares Outstanding | 241 | 236 | 233 | 231 | 219 | 207 |
Shares Change (YoY) | 2.41% | 1.40% | 0.80% | 5.42% | 5.70% | 10.17% |
EPS (Basic) | 0.74 | 0.54 | 0.06 | -0.34 | -0.52 | 0.67 |
EPS (Diluted) | 0.73 | 0.54 | 0.06 | -0.34 | -0.52 | 0.67 |
EPS Growth | 78.50% | 807.61% | - | - | - | 81.76% |
Dividend Per Share | 1.200 | 1.200 | 1.200 | 1.200 | 1.200 | 1.350 |
Dividend Growth | - | - | - | - | -11.11% | -25.00% |
Operating Margin | 37.83% | 36.49% | 33.91% | 26.66% | 7.58% | 42.93% |
Profit Margin | 23.44% | 18.03% | 2.13% | -14.59% | -29.17% | 23.04% |
EBITDA | 455.63 | 421.19 | 395.89 | 323 | 221.94 | 433.8 |
EBITDA Margin | 60.99% | 59.94% | 61.41% | 60.72% | 57.17% | 72.20% |
D&A For Ebitda | 173.03 | 164.76 | 177.27 | 181.16 | 192.5 | 175.89 |
EBIT | 282.6 | 256.43 | 218.62 | 141.84 | 29.44 | 257.92 |
EBIT Margin | 37.83% | 36.49% | 33.91% | 26.66% | 7.58% | 42.93% |
Funds From Operations (FFO) | 356.16 | 321.61 | 296.5 | 295.88 | 253.22 | 346.53 |
FFO Per Share | 1.48 | 1.36 | 1.27 | 1.28 | 1.15 | 1.67 |
Adjusted Funds From Operations (AFFO) | - | 338.19 | 311.33 | 333.02 | 297.14 | 361.17 |
AFFO Per Share | - | 1.43 | 1.33 | 1.43 | 1.35 | 1.74 |
FFO Payout Ratio | 80.21% | 87.11% | 93.57% | 93.67% | 103.83% | 80.31% |
Effective Tax Rate | 0.98% | 0.79% | 12.71% | - | - | 0.51% |
Revenue as Reported | 745.08 | 703.24 | 647.51 | 624.81 | 569.55 | 598.57 |
Source: S&P Global Market Intelligence. Real Estate template. Financial Sources.